Posts Tagged 'bard'

New Study: Retrievable IVC Filters Offer No Benefit

retrievable ivc filters shown to have no benefitAccording to a new study published in the Journal of the American Medical Association, retrievable interior vena cava (IVC) filters offer “no benefit in terms of pulmonary embolism recurrence or mortality”. A recent Forbes article details the results of the study and their significance to IVC filter use.

According to Forbes, the study was conducted by a team of French physicians ...

continue reading...

Lopez McHugh IVC Trial Ends With Settlement

On January 26, 2015, Lopez McHugh represented a plaintiff in the second lawsuit in the nation to proceed to trial against Bard for its defective inferior vena cava filters. Ramon Rossi Lopez was lead trial counsel in the case, which involved a Recovery Filter that migrated to and punctured a hole in the plaintiff’s heart, leading to emergency open heart surgery. After 11 days of trial, Bard made a confidential settlement offer, which was accepted ...

continue reading...

Lopez McHugh Overcomes Attempts to Dismiss IVC Filter Lawsuit

On December 16, 2014, the District Court of Nevada refused to dismiss the lawsuit Phillips v. C.R. Bard, Inc., one of many cases involving a device called an inferior vena cava filter (or IVC filter). The Lopez McHugh law firm is representing consumers who have suffered catastrophic injuries, including death, due to Bard’s defective IVC filters.

An IVC filter is intended to prevent blood clots from traveling to the heart or lungs, which can cause serious injuries or ...

continue reading...

Judge Allows Bard IVC Plaintiffs to Proceed with IVC Lawsuit

Plaintiffs in IVC lawsuits, alleging serious injuries from fractured or migrated Bard inferior vena cava filters, recently won a significant victory in court against Bard Peripheral Vascular and C.R. Bard.

In the California Superior Court where a number of IVC lawsuits are pending, Judge Sturgeon denied Bard’s motion for summary judgment. The motion was a procedural tool that allows a defendant in a lawsuit to avoid trial by arguing that there is insufficient evidence for the plaintiffs to prove their case. ...

continue reading...

Bard Settles Vaginal Mesh Case Before Trial

Bloomberg.com is reporting that C.R. Bard Inc. has agreed to settle a claim involving one of the company’s vaginal mesh implants. The case involving a New Jersey woman’s claim that Bard’s Avaulta Plus insert caused her internal problems including urinary problems was scheduled to begin on September 23, 2013 in the Superior Court of New Jersey in Atlantic City.

Last month, a federal jury in Charleston, WV awarded a woman $2 million dollars for injuries that were ...

continue reading...

CR Bard to Buy Rochester Medical for $262 Million

According to Reuters, CR Bard Inc., a New Jersey-based medical device company, has announced that it will buy Rochester Medical Inc. for $262 million to gain market share in the urology homecare market.

Reuters states that Bard will pay $20 per share, or 45 percent more than the recent stock price.

Bard is currently defending ongoing lawsuits involving its IVC filter. There have been reports of a 25 percent failure rate involving a small group of patients ...

continue reading...
Page 6 of 6 «...23456